Zhengye Biotechnology Holding Limited Statutory Accounting Practices, Statutory Capital and Surplus, Balance
Zhengye Biotechnology Holding Limited (ZYBT) had Statutory Accounting Practices, Statutory Capital and Surplus, Balance of CNY 32.65 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Notes
us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance · last filed 2026-04-28
- 2025-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance 32.65M CNY.
- 2025-06-30: Statutory Accounting Practices, Statutory Capital and Surplus, Balance 32.65M CNY.
- 2024-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance 32.65M CNY.
- 2023-12-31: Statutory Accounting Practices, Statutory Capital and Surplus, Balance 31.31M CNY.
CNY
| Period end | Statutory Accounting Practices, Statutory Capital and Surplus, Balance |
|---|---|
| 2025-12-31 | 32.65M CNY 20-F · filed 2026-04-28 |
| 2025-06-30 | 32.65M CNY 6-K · filed 2025-12-12 |
| 2024-12-31 | 32.65M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 31.31M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Statutory Accounting Practices, Statutory Capital and Surplus, Balance |
|---|---|
| 2025-12-31 | $4.67M 20-F · filed 2026-04-28 |
| 2025-06-30 | $4.56M 6-K · filed 2025-12-12 |
| 2024-12-31 | $4.47M 20-F · filed 2025-07-03 |